Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effectiveness of the Belatacept (Nulojix®) Patient Alert Cards in Patients Following Renal Transplantation in European Economic Area Countries

NCT02581644 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT02581644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02581644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effectiveness of the Belatacept (Nulojix®) Patient Alert Cards in Patients Following Renal Transplantation in European Economic Area Countries
Lead sponsor
Bristol-Myers Squibb
Phase
Observational
Overall status
Completed
Start date
November 29, 2016
Completion date
May 19, 2017
Enrollment
63 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplant